Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Classifying a cancer disease using CAIX expression

Classifying a cancer disease using CAIX expression

US Patent 10620208 · Granted Apr 14, 2020

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods for assessing the treatment response of TNBC patients to neo-adjuvant ch2022
Adjuvant theraphy of G250-expressing tumors2010
Diagnostic and therapeutic use of antibodies against the urokinase receptor2008
Urokinase inhibitors and uses thereof2008
Cyclic peptidomimetic urokinase receptor antagonists2008
Selective inhibitors of the urokinase plasminogen activator2007
Highly selective inhibitors of the urokinase plasminogen activator2006
Selective inhibitors of the urokinase plasminogen activator2006
Cyclic peptidomimetic urokinase receptor antagonists2006
Cyclic peptidomimetic urokinase receptor antagonists2005
Inhibitors for urokinase receptor2005
Highly selective inhibitors of the urokinase plasminogen activator2005